×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| BHARAT IMMUNOLOGICALS & BIOLOG | NA | NA | NA | NA | 109.0 | |
| Mercury Laboratories Limited | NA | NA | NA | NA | 98.2 | 26.1 |
| Rajnish Wellness Limited | NA | NA | NA | NA | 97.5 | 886.0 |
Bharat Immunologicals & Biologicals, with Security Code 524663, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2019 | Dec 2019 | Jun 2020 | Sep 2020 | Dec 2020 | Jun 2021 | Sep 2021 | Dec 2021 | Sep 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.1 | 28.5 | 19.2 | 25.4 | 25.2 | 14.2 | 24.7 | 17.4 | 26.5 | 0.0 |
| Expenses | 14.8 | 30.5 | 18.5 | 29.9 | 27.5 | 13.2 | 28.2 | 16.4 | 29.0 | 4.7 |
| Operating Profit | -6.7 | -2.0 | 0.6 | -4.5 | -2.3 | 1.0 | -3.5 | 1.0 | -2.5 | -4.7 |
| OPM % | -82.62% | -7.06% | 3.28% | -17.74% | -9.02% | 7.3% | -14.13% | 5.83% | -9.44% | 0% |
| Other Income | 0.2 | 0.5 | -0.6 | 0.1 | 1.2 | 0.2 | 0.2 | 0.1 | 0.3 | 0.1 |
| Interest | 1.2 | 1.6 | 1.1 | 1.2 | 1.3 | 1.2 | 1.2 | 1.5 | 1.7 | 1.7 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -7.8 | -3.2 | -1.1 | -5.6 | -2.4 | 0.1 | -4.6 | -0.4 | -4.0 | -6.3 |
| Tax % | -27.7% | -26.6% | -28.9% | -30.8% | -22% | 2539.7% | 105.3% | -25% | -22.1% | -26% |
| Net Profit | -5.7 | -2.4 | -0.8 | -3.9 | -1.9 | 1.9 | -9.4 | -0.3 | -3.1 | -4.7 |
| EPS in Rs | -1.28 | -0.54 | -0.18 | -0.9 | -0.44 | 0.45 | -2.17 | -0.08 | -0.71 | -1.08 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 5% |
| 3 Years: | -13% |
| TTM: | -90% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -31% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 5% |
| 3 Years: | -5% |
| 1 Year: | -20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|